Cobbold, Simon A.

Structure of human PINK1 at a mitochondrial TOM-VDAC array

Callegari, S., Kirk, N. S., Gan, Z. Y., Dite, T., Cobbold, S. A., Leis, A., Dagley, L. F., Glukhova, A., & Komander, D. (2025) · Science

Mitochondrial Function and PathologyParkinson's Disease Mechanisms and Treatments

Cited by 75

Development of NanoLuc-targeting protein degraders and a universal reporter system to benchmark tag-targeted degradation platforms

Grohmann, C., Magtoto, C. M., Walker, J. R., Chua, N. K., Gabrielyan, A., Hall, M., Cobbold, S. A., Mieruszynski, S., Brzozowski, M., Simpson, D. S., et al. (2022) · Nature Communications

Protein Degradation and InhibitorsUbiquitin and proteasome pathways

Cited by 43

Major histocompatibility class II in murine antigen presenting cells is modified with a branched K63 and K11-linked ubiquitin chain

Liu, H., Francis, L., Dagley, L. F., Cobbold, S. A., Webb, A. I., Komander, D., Villadangos, J. A., & Mintern, J. D. (2025) · Scientific Reports

Ubiquitin and proteasome pathwaysImmunotherapy and Immune Responses

Cited by 2

Major histocompatibility class II in murine antigen presenting cells is modified with a branched K63 and K11-linked ubiquitin chain

Liu, H., Francis, L., Dagley, L. F., Cobbold, S. A., Webb, A. I., Komander, D., Villadangos, J. A., & Mintern, J. D. (2025) · Scientific Reports

Ubiquitin and proteasome pathwaysImmunotherapy and Immune Responses

Cited by 2